Advertisement

Topics

ALKS Pulls Off Sweet Surprise, APRI Thrashed, BMY Gets FDA Nod

02:40 EDT 17 Apr 2018 | RTTNews

Today's Daily Dose brings you news about Alkermes' curious reversal of event; outcome of Apricus' end-of-review meeting with the FDA related to Vitaros; FDA approval of Bristol-Myers Squibb Co.'s Immuno-Oncology combination therapy, and Merck's KEYNOTE-189 study.

Original Article: ALKS Pulls Off Sweet Surprise, APRI Thrashed, BMY Gets FDA Nod

NEXT ARTICLE

More From BioPortfolio on "ALKS Pulls Off Sweet Surprise, APRI Thrashed, BMY Gets FDA Nod"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...